Work

Table S1 from A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors

Year: 2024

Type: other

Abstract: Representativeness of Study Participants

DOI: 10.1158/2767-9764.26644199

Authors: Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio De Vito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4401588705

Cites:

Cited by:

Related to: 10